Dyne Therapeutics Inc
NASDAQ:DYN
Dyne Therapeutics Inc
NASDAQ:DYN
Price:
17.56
USD
-1.35%
Market Closed
Market Cap:
$2.8B
Cash Flow Statement
Cash Flow Statement
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Currency: USD
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(42)
|
(59)
|
(84)
|
(97)
|
(126)
|
(149)
|
(160)
|
(182)
|
(181)
|
(168)
|
(177)
|
(189)
|
(208)
|
(236)
|
(257)
|
(258)
|
(295)
|
(317)
|
(367)
|
(413)
|
(424)
|
(446)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
2
|
7
|
10
|
14
|
16
|
18
|
18
|
17
|
17
|
15
|
15
|
17
|
18
|
20
|
35
|
37
|
41
|
46
|
39
|
43
|
45
|
46
|
|
| Other Non-Cash Items |
5
|
7
|
11
|
16
|
18
|
19
|
21
|
21
|
20
|
18
|
17
|
17
|
18
|
20
|
35
|
36
|
39
|
43
|
36
|
40
|
43
|
44
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
|
| Change in Working Capital |
3
|
5
|
7
|
(16)
|
(4)
|
9
|
(15)
|
23
|
7
|
(5)
|
8
|
(4)
|
6
|
26
|
1
|
1
|
11
|
(19)
|
10
|
11
|
3
|
(3)
|
|
| Cash from Operating Activities |
(33)
N/A
|
(47)
-39%
|
(65)
-40%
|
(96)
-49%
|
(112)
-16%
|
(120)
-7%
|
(152)
-27%
|
(137)
+10%
|
(153)
-12%
|
(154)
-1%
|
(150)
+2%
|
(175)
-17%
|
(182)
-4%
|
(188)
-3%
|
(220)
-17%
|
(219)
+0%
|
(243)
-11%
|
(292)
-20%
|
(320)
-9%
|
(360)
-12%
|
(376)
-4%
|
(403)
-7%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(21)
|
(21)
|
|
| Other Items |
0
|
(45)
|
(173)
|
(179)
|
(181)
|
(134)
|
(7)
|
18
|
72
|
90
|
118
|
117
|
78
|
84
|
(123)
|
(128)
|
(160)
|
(202)
|
(20)
|
(25)
|
(24)
|
(8)
|
|
| Cash from Investing Activities |
(2)
N/A
|
(46)
-2 291%
|
(174)
-281%
|
(180)
-4%
|
(183)
-1%
|
(138)
+25%
|
(12)
+92%
|
13
N/A
|
68
+412%
|
87
+29%
|
116
+33%
|
115
-1%
|
76
-34%
|
83
+9%
|
(124)
N/A
|
(130)
-5%
|
(162)
-25%
|
(204)
-26%
|
(23)
+89%
|
(27)
-19%
|
(46)
-68%
|
(29)
+37%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
382
|
381
|
538
|
537
|
157
|
158
|
1
|
1
|
0
|
37
|
66
|
91
|
91
|
54
|
434
|
789
|
806
|
810
|
543
|
165
|
365
|
743
|
|
| Net Issuance of Debt |
10
|
(0)
|
(0)
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
99
|
98
|
148
|
|
| Other |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
392
N/A
|
381
-3%
|
538
+41%
|
526
-2%
|
147
-72%
|
158
+8%
|
1
-100%
|
1
+12%
|
0
-58%
|
37
+13 254%
|
66
+77%
|
91
+37%
|
91
+0%
|
54
-41%
|
434
+699%
|
789
+82%
|
806
+2%
|
810
+0%
|
543
-33%
|
264
-51%
|
463
+76%
|
890
+92%
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
357
N/A
|
289
-19%
|
299
+4%
|
249
-17%
|
(148)
N/A
|
(100)
+33%
|
(163)
-64%
|
(123)
+25%
|
(84)
+31%
|
(29)
+66%
|
33
N/A
|
32
-4%
|
(15)
N/A
|
(51)
-246%
|
91
N/A
|
440
+386%
|
401
-9%
|
313
-22%
|
200
-36%
|
(123)
N/A
|
42
N/A
|
458
+1 004%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(35)
N/A
|
(48)
-35%
|
(66)
-39%
|
(98)
-48%
|
(114)
-16%
|
(123)
-8%
|
(157)
-27%
|
(141)
+10%
|
(157)
-11%
|
(157)
+0%
|
(152)
+3%
|
(176)
-16%
|
(184)
-4%
|
(189)
-3%
|
(220)
-17%
|
(220)
+0%
|
(244)
-11%
|
(295)
-21%
|
(323)
-10%
|
(362)
-12%
|
(397)
-10%
|
(424)
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
